ArticleOrthopaedic journal of sports medicine2025
Long-term Results of Bone-Patellar Tendon-Bone Versus Hamstring Tendon Autograft for Primary Anterior Cruciate Ligament Reconstruction: A Meta-analysis of Randomized Controlled Trials.
Article in Orthopaedic journal of sports medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Anterior Cruciate Ligament Reconstruction: Clinical Outcomes and Biomechanical Considerations of Graft Selection-A Narrative Review.Medicina (Kaunas, Lithuania) · 2026Review
- Structural severity versus clinical reality: Are we measuring the right endpoints?Journal of experimental orthopaedics · 2026Article
- Factors Associated with Quadriceps Strength Recovery at 6 and 12 Months After Anterior Cruciate Ligament Reconstruction Using Quadriceps Tendon-Bone, Bone-Patellar Tendon-Bone, and Hamstring Tendon Autografts.Orthopaedic journal of sports medicine · 2026Article
- Effect of a Visual Dual-Task on Single-Leg Countermovement-Jump in Male Professional Soccer Players with Lower-Limb Injuries: A Cross-Sectional Observational Study.Sports (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Bone-patellar tendon-bone (BTB) and hamstring tendon (HT) autografts are the most commonly utilized grafts for primary anterior cruciate ligament reconstruction (ACLR). While previous studies have compared outcomes using BTB and HT grafts for ACLR at short- and mid-term follow-ups, outcomes at long-term follow-ups remain unclear. Purpose: To perform a systematic review and meta-analysis of randomized controlled trials (RCTs) evaluating BTB versus HT autografts for primary ACLR at a minimum 10-year follow-up. Study Design: Systematic review; Level of evidence, 2. Methods: A systematic review was performed in accordance with the 2020 PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines by querying 5 databases from inception through May 2024 to identify level 1 and 2 RCTs evaluating outcomes of BTB versus HT autografts for primary ACLR at a minimum 10-year follow-up. A meta-analysis was performed using random-effects models with risk ratios (RRs) for discrete outcomes and mean differences (MDs) for continuous outcomes. Results: Six RCTs-consisting of 495 (BTB, n = 235; HT, n = 260) patients-were identified. The mean age at the follow-up was 41.3 ± 7.4 years, with men comprising 64% (n = 316/495) of patients. The mean final follow-up time was 14.6 ± 0.7 years (range, 10-17 years). No significant differences were observed in ACL graft rupture or revision rates (RR, 0.88; Conclusion: BTB and HT autografts for primary ACLR demonstrate similar outcomes and rates of OA progression at long-term follow-ups. Knees undergoing ACLR have a greater risk of OA progression compared with healthy contralateral knees.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.